secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANNKIND CORP (MNKD)
CIK:        0000899460
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000950170-23-060230
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MannKind Q3 total revenue $51M, up 56% YoY; net income $2M GAAP
---------------------------------------------------------------

- Total revenue $51.3M, +56% YoY; net income $2M (GAAP); non-GAAP net income $4M.
- Tyvaso DPI royalties $20.2M, +225% YoY, driven by patient demand.
- Afrezza net revenue $13.5M, +24% YoY on higher demand and price; V-Go down 18%.
- Cash and investments $144.3M; R&D spending rose to $10M (vs $4.1M) on pipeline MNKD-101.
- Commercial product gross margin improved to 78% from 69% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899460/000095017023060230/0000950170-23-060230-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899460/000095017023060230/mnkd-20231107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060230

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer